OPENLAB VERIFIED
Report identity and source-transcribed quantity. Compound purity and analytical events retain their separate source scopes.
YK-11
- Batch
- OL2288
- Report
- R41331
- Laboratory
- Janoshik Analytical
- Analysed
- 26 April 2024
Powered by EvidenceOS, connecting this Olympus Labs UK product and batch to its laboratory results and source evidence.
Hover to inspect · enlarge for scroll, pan and zoom
Six checks for this batch.
- Product
- YK-11
- Batch
- OL2288
- Report
- R41331
- 01✓
- 02✓
- 03✓
- 04✓
- 05✓
Raw material to finished product
Follow the product from raw-material purity testing to the finished-product laboratory report. Each result describes a distinct stage.
- 01 · Raw-material sampleOwner-associated sample
Pre-production purity assay
- 02 · Raw-material lotIdentifier not supplied
Used in the production batch
- 03 · Production batchOL2288
Finished capsules
- 04 · Finished-product testJanoshik R41331
Concentration and identification
- Laboratory sample
- 1774-2 SARMs 80529-14 YK-11
Production linkage and source coverage
The product owner confirms that the pre-production raw material was used in this production batch, whose finished capsules were sampled for concentration and identification testing. Laboratory observations retain their own sample and event identities.
Confirmed by Product owner, 2026-09-07. External identifiers remain unfilled where they were not supplied.
- External raw-material sample and lot identifiers are not supplied.
- Raw-material purity is publisher-reported; an independent purity-result page is not supplied.
- Laboratory sample/batch identifier 80529-14 is distinct from production batch OL2288. The owner confirms their production linkage. Independent OL2288 purity is an accepted source limitation. Method settings and the 2016 historical result do not establish that purity.
Analytical results
- Report
- R41331
- Batch
- OL2288
- Recorded
- 26 April 2024
- Signal
- PDA Ch1 220–260 nm
OPENLAB / ANALYTICAL EVIDENCE
Concentration
Discrete quantity measurements from the selected analytical run.
View data table
| Peak | Retention time (min) | Quantity (mg) |
|---|---|---|
| 1 | 2.297 | 10.233 |
OPENLAB / ANALYTICAL EVIDENCE
Compound identity
The expected compound, observed identification and source conclusion stay together.
- Product
- YK-11
- Compound
- YK-11
- Report
- R41331
OPENLAB / ANALYTICAL EVIDENCE
Measured quantity
The source result, with its original unit and sample basis.
- Compound
- YK-11
- Sample
- Reported sample; the laboratory gives mg without a per-capsule denominator.
OPENLAB / ANALYTICAL EVIDENCE
Reported purity
The source result, with its original unit and sample basis.
- Compound
- YK-11
- Sample
- Compound raw material
“>99.99%” means more than the stated amount. The source does not give an exact value above that limit.
OPENLAB / ANALYTICAL EVIDENCE
YK-11 · PDA Ch1 220–260 nm · 2024-04-26
Inspect the whole source image, then zoom into its recorded detail.
Fit · complete source image · Use zoom controls, then scroll inside the image to inspect detail.
Analytical methods
Chromatography
- Signal
- PDA Ch1 220–260 nm
- Recorded
- 26 April 2024
- Testing ordered
- 11 April 2024
- Sample received
- 23 April 2024
- Analysed
- 26 April 2024
Janoshik Analytical
- Report
- R41331
- Batch
- OL2288
Explore the available findings and source evidence for YK-11.
YK-11
- Batch
- OL2288
- Report
- R41331